Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Anatomy, Bony Pelvis and Lower Limb, Iliotibial Band (Tract).

Hyland S, Varacallo M.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2019 Jan 4.

2.

Clinical pharmacist perspectives for optimizing pharmacotherapy within Enhanced Recovery After Surgery (ERAS®) Programs.

Lovely JK, Hyland SJ, Smith AN, Nelson G, Ljungqvist O, Parrish RH 2nd.

Int J Surg. 2019 Jan 18. pii: S1743-9191(19)30012-3. doi: 10.1016/j.ijsu.2019.01.006. [Epub ahead of print] Review.

PMID:
30665004
3.

Liposomal Bupivacaine Versus Standard Periarticular Injection in Total Knee Arthroplasty With Regional Anesthesia: A Prospective Randomized Controlled Trial.

Hyland SJ, Deliberato DG, Fada RA, Romanelli MJ, Collins CL, Wasielewski RC.

J Arthroplasty. 2018 Nov 23. pii: S0883-5403(18)31154-9. doi: 10.1016/j.arth.2018.11.026. [Epub ahead of print]

PMID:
30554925
4.

Anatomy, Bony Pelvis and Lower Limb, Popliteal Region.

Hyland S, Varacallo M.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Nov 14.

5.

Anatomy, Bony Pelvis and Lower Limb, Popliteus Muscle.

Hyland S, Varacallo M.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Nov 14.

6.

Anatomy, Shoulder and Upper Limb, Clavicle.

Hyland S, Varacallo M.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

7.

Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.

Williams AM, Shah R, Shayne M, Huston AJ, Krebs M, Murray N, Thompson BD, Doyle K, Korotkin J, van Wijngaarden E, Hyland S, Moynihan JA, Cory-Slechta DA, Janelsins MC.

J Neuroimmunol. 2018 Jan 15;314:17-23. doi: 10.1016/j.jneuroim.2017.10.005. Epub 2017 Oct 18.

8.

Pictograms for Safer Medication Management by Health Care Workers.

Vaillancourt R, Pouliot A, Streitenberger K, Hyland S, Thabet P.

Can J Hosp Pharm. 2016 Jul-Aug;69(4):286-93. Epub 2016 Aug 31.

9.

Responding to the challenge of look-alike, sound-alike drug names.

Trbovich PL, Hyland S.

BMJ Qual Saf. 2017 May;26(5):357-359. doi: 10.1136/bmjqs-2016-005629. Epub 2016 Aug 23. No abstract available.

PMID:
27555615
10.

From the Battlefield to the Bedside: Supporting Warfighter and Civilian Health With the "ART" of Whole Genome Sequencing for Antibiotic Resistance and Outbreak Investigations.

Lesho E, Lin X, Clifford R, Snesrud E, Onmus-Leone F, Appalla L, Ong A, Maybank R, Nielsen L, Kwak Y, Hinkle M, Turco J, Marin JA, Hooks S, Matthews S, Hyland S, Little J, Waterman P, McGann P.

Mil Med. 2016 Jul;181(7):621-4. doi: 10.7205/MILMED-D-15-00197.

PMID:
27391613
11.

Rates of workplace aggression in the emergency department and nurses' perceptions of this challenging behaviour: A multimethod study.

Hyland S, Watts J, Fry M.

Australas Emerg Nurs J. 2016 Aug;19(3):143-8. doi: 10.1016/j.aenj.2016.05.002. Epub 2016 May 31.

PMID:
27259588
12.

The behavioral characteristics of Sotos syndrome.

Sheth K, Moss J, Hyland S, Stinton C, Cole T, Oliver C.

Am J Med Genet A. 2015 Dec;167A(12):2945-56. doi: 10.1002/ajmg.a.37373. Epub 2015 Sep 29.

PMID:
26418839
13.

Identification of active transcriptional regulatory elements from GRO-seq data.

Danko CG, Hyland SL, Core LJ, Martins AL, Waters CT, Lee HW, Cheung VG, Kraus WL, Lis JT, Siepel A.

Nat Methods. 2015 May;12(5):433-8. doi: 10.1038/nmeth.3329. Epub 2015 Mar 23.

14.

Emergency nurses' perceptions of the role of confidence, self-efficacy and reflexivity in managing the cognitively impaired older person in pain.

Fry M, MacGregor C, Hyland S, Payne B, Chenoweth L.

J Clin Nurs. 2015 Jun;24(11-12):1622-9. doi: 10.1111/jocn.12763. Epub 2015 Feb 9.

PMID:
25664932
15.

Vasopressor stewardship: a case report and lesson shared.

Koczmara CK, St-Arnaud C, Martinez HQ, Adhikari NK, Meade M, Bérard D, Leclair MA, Hyland S, Côté L, Torres E, Fontaine L, Béland F, Martel A, Samson S, Dubreuil J, Lagueux G, Lamarre P, Langevin C, Lamontagne F.

Dynamics. 2014 Spring;25(1):26-9.

PMID:
24716392
16.

Measuring kidney patients' motivation to pursue living donor kidney transplant: development of stage of change, decisional balance and self-efficacy measures.

Waterman AD, Robbins ML, Paiva AL, Peipert JD, Davis LA, Hyland SS, Schenk EA, Baldwin KA, Amoyal NR.

J Health Psychol. 2015 Feb;20(2):210-21. doi: 10.1177/1359105313501707. Epub 2013 Oct 22.

17.

Modifiable patient characteristics and racial disparities in evaluation completion and living donor transplant.

Waterman AD, Peipert JD, Hyland SS, McCabe MS, Schenk EA, Liu J.

Clin J Am Soc Nephrol. 2013 Jun;8(6):995-1002. doi: 10.2215/CJN.08880812. Epub 2013 Mar 21.

18.

Review article: improving drug safety for patients undergoing anesthesia and surgery.

Orser BA, Hyland S, U D, Sheppard I, Wilson CR.

Can J Anaesth. 2013 Feb;60(2):127-35. doi: 10.1007/s12630-012-9853-y. Epub 2012 Dec 22. Review.

PMID:
23264011
19.

Distinct activities of the anaphase-promoting complex/cyclosome (APC/C) in mouse embryonic cells.

Yang VS, Carter SA, Ng Y, Hyland SJ, Tachibana-Konwalski K, Fisher RA, Sebire NJ, Seckl MJ, Pedersen RA, Laskey RA, Gonzalez MA.

Cell Cycle. 2012 Mar 1;11(5):846-55. doi: 10.4161/cc.11.5.19251. Epub 2012 Mar 1.

20.

Natural outbreak of Streptococcus agalactiae (GBS) infection in wild giant Queensland grouper, Epinephelus lanceolatus (Bloch), and other wild fish in northern Queensland, Australia.

Bowater RO, Forbes-Faulkner J, Anderson IG, Condon K, Robinson B, Kong F, Gilbert GL, Reynolds A, Hyland S, McPherson G, Brien JO, Blyde D.

J Fish Dis. 2012 Mar;35(3):173-86. doi: 10.1111/j.1365-2761.2011.01332.x.

PMID:
22324342
21.

SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors.

Lu Z, Chen YH, Napolitano JB, Taylor G, Ali A, Hammond ML, Deng Q, Tan E, Tong X, Xu SS, Latham MJ, Peterson LB, Anderson MS, Eveland SS, Guo Q, Hyland SA, Milot DP, Chen Y, Sparrow CP, Wright SD, Sinclair PJ.

Bioorg Med Chem Lett. 2012 Jan 1;22(1):199-203. doi: 10.1016/j.bmcl.2011.11.039. Epub 2011 Nov 16.

PMID:
22142541
22.

Drug name alert: potential for confusion between pradax and plavix.

Koczmara C, Hyland S.

Dynamics. 2011 Fall;22(3):25-6.

PMID:
21941815
23.

Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib.

Smith CJ, Ali A, Hammond ML, Li H, Lu Z, Napolitano J, Taylor GE, Thompson CF, Anderson MS, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Sparrow CP, Wright SD, Cumiskey AM, Latham M, Peterson LB, Rosa R, Pivnichny JV, Tong X, Xu SS, Sinclair PJ.

J Med Chem. 2011 Jul 14;54(13):4880-95. doi: 10.1021/jm200484c. Epub 2011 Jun 17.

PMID:
21682257
24.

Discovery of substituted biphenyl oxazolidinone inhibitors of cholesteryl ester transfer protein.

Thompson CF, Ali A, Quraishi N, Lu Z, Hammond ML, Sinclair PJ, Anderson MS, Eveland SS, Guo Q, Hyland SA, Milot DP, Sparrow CP, Wright SD.

ACS Med Chem Lett. 2011 Mar 24;2(6):424-7. doi: 10.1021/ml100309n. eCollection 2011 Jun 9.

25.

Geminin escapes degradation in G1 of mouse pluripotent cells and mediates the expression of Oct4, Sox2, and Nanog.

Yang VS, Carter SA, Hyland SJ, Tachibana-Konwalski K, Laskey RA, Gonzalez MA.

Curr Biol. 2011 Apr 26;21(8):692-9. doi: 10.1016/j.cub.2011.03.026. Epub 2011 Apr 14.

26.

ALERT: mix-ups between conventional and lipid formulations of amphotericin B can be extremely dangerous.

Koczmara C, Richardson H, Hyland S, Lee CS, Hillebrand N.

Dynamics. 2011 Spring;22(1):24-6.

PMID:
21469498
27.

2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy.

Sweis RF, Hunt JA, Sinclair PJ, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Cumiskey AM, Latham M, Rosa R, Peterson L, Sparrow CP, Anderson MS.

Bioorg Med Chem Lett. 2011 May 1;21(9):2597-600. doi: 10.1016/j.bmcl.2011.02.049. Epub 2011 Feb 23.

PMID:
21398121
28.

2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy.

Sweis RF, Hunt JA, Kallashi F, Hammond ML, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Cumiskey AM, Latham M, Rosa R, Peterson L, Sparrow CP, Wright SD, Anderson MS, Sinclair PJ.

Bioorg Med Chem Lett. 2011 Mar 15;21(6):1890-5. doi: 10.1016/j.bmcl.2010.11.090. Epub 2010 Nov 25.

PMID:
21147531
29.

2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.

Kallashi F, Kim D, Kowalchick J, Park YJ, Hunt JA, Ali A, Smith CJ, Hammond ML, Pivnichny JV, Tong X, Xu SS, Anderson MS, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Cumiskey AM, Latham M, Peterson LB, Rosa R, Sparrow CP, Wright SD, Sinclair PJ.

Bioorg Med Chem Lett. 2011 Jan 1;21(1):558-61. doi: 10.1016/j.bmcl.2010.10.062. Epub 2010 Oct 20.

PMID:
21094047
30.

Design of a novel class of biphenyl CETP inhibitors.

Lu Z, Napolitano JB, Theberge A, Ali A, Hammond ML, Tan E, Tong X, Xu SS, Latham MJ, Peterson LB, Anderson MS, Eveland SS, Guo Q, Hyland SA, Milot DP, Chen Y, Sparrow CP, Wright SD, Sinclair PJ.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7469-72. doi: 10.1016/j.bmcl.2010.10.019. Epub 2010 Oct 15.

PMID:
21041082
31.

Hospitals report on medication safety in Canada.

Greenall J, Lefebvre P, Hyland S, Salsman B.

Dynamics. 2010 Fall;21(3):28-30.

PMID:
20836422
32.

Checking it twice: an evaluation of checklists for detecting medication errors at the bedside using a chemotherapy model.

White RE, Trbovich PL, Easty AC, Savage P, Trip K, Hyland S.

Qual Saf Health Care. 2010 Dec;19(6):562-7. doi: 10.1136/qshc.2009.032862. Epub 2010 Aug 19. Erratum in: Qual Saf Health Care. 2011 May;20(5):396.

33.

Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.

Ozdemir V, Husereau D, Hyland S, Samper S, Salleh MZ.

Curr Pharmacogenomics Person Med. 2009 Dec;7(4):225-230. No abstract available.

34.

Kidney patients' intention to receive a deceased donor transplant: development of stage of change, decisional balance and self-efficacy measures.

Waterman AD, Robbins ML, Paiva AL, Hyland SS.

J Health Psychol. 2010 Apr;15(3):436-45. doi: 10.1177/1359105309351248.

35.

2-Arylbenzoxazoles as CETP inhibitors: substitution and modification of the alpha-alkoxyamide moiety.

Hunt JA, Gonzalez S, Kallashi F, Hammond ML, Pivnichny JV, Tong X, Xu SS, Anderson MS, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Sparrow CP, Wright SD, Sinclair PJ.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1019-22. doi: 10.1016/j.bmcl.2009.12.046. Epub 2009 Dec 16.

PMID:
20036121
36.

Pharmaceutical bar coding: moving forward in Canada.

Sheppard I, Hyland S, Leonard P, Koczmara C.

Dynamics. 2009 Fall;20(3):28-30.

PMID:
19953758
37.

2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety.

Smith CJ, Ali A, Chen L, Hammond ML, Anderson MS, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Sparrow CP, Wright SD, Sinclair PJ.

Bioorg Med Chem Lett. 2010 Jan 1;20(1):346-9. doi: 10.1016/j.bmcl.2009.10.099. Epub 2009 Oct 29. Erratum in: Bioorg Med Chem Lett. 2010 Dec 15;20(24):7555.

PMID:
19914065
38.

Hospital-acquired acute hyponatremia and parenteral fluid administration in children.

Koczmara C, Hyland S, Greenall J.

Can J Hosp Pharm. 2009 Nov;62(6):512-5. No abstract available.

39.

ALERT: Revatio is another brand name for sildenafil.

Koczmara C, Hyland S, Greenall J.

Dynamics. 2009 Spring;20(2):41-2.

PMID:
19558084
40.

A near miss involving cyclophosphamide.

Koczmara C, Broadfield L, Hyland S, Cheng R.

Dynamics. 2009 Spring;20(1):25-6.

PMID:
19331060
41.

Enhancing safe medication use for pediatric patients in the emergency department.

Greenall J, Santora P, Koczmara C, Hyland S.

Can J Hosp Pharm. 2009 Mar;62(2):150-3. No abstract available.

42.

Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.

Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N, Dwerryhouse S, Lao-Sirieix P, Caldas C, Fitzgerald RC.

J Pathol. 2008 Nov;216(3):295-306. doi: 10.1002/path.2426.

PMID:
18788075
43.

Desmopressin (dDAVP) incident signals the need for enhanced monitoring protocols.

Campigotto MJ, Koczmara C, Greenall J, Hyland S.

Dynamics. 2008 Fall;19(3):34-6. Review.

PMID:
18773714
44.

Commentary: reflections on the culture of the Lower Mississippi Delta: challenges and opportunities.

Hyland S.

J Health Hum Serv Adm. 2008 Summer;31(1):156-67. No abstract available.

PMID:
18575153
45.

Still a long way to go for the Lower Mississippi Delta.

Gnuschke JE, Hyland S, Wallace J, Hanson R, Smith S.

J Health Hum Serv Adm. 2008 Summer;31(1):72-104.

PMID:
18575149
46.

Using human factors methods to evaluate the labelling of injectable drugs.

Momtahan K, Burns CM, Jeon J, Hyland S, Gabriele S.

Healthc Q. 2008;11(3 Spec No.):122-8.

47.

Medication safety in the operating room: teaming up to improve patient safety.

Merali R, Orser BA, Leeksma A, Lingard S, Belo S, Hyland S.

Healthc Q. 2008;11(3 Spec No.):54-7.

48.

Preventing substitution errors involving high-concentration heparin products.

Koczmara C, Cheng R, Hyland S.

Dynamics. 2008 Spring;19(1):32-4. Review.

PMID:
18416360
49.

Enhancing safety with potassium phosphates injection.

Cornish P, Hyland S, Koczmara C.

Dynamics. 2007 Winter;18(4):34-6.

PMID:
18274363
50.

Epidural medications given intravenously may result in death.

Koczmara C, Hyland S, Cheng R.

Dynamics. 2007 Fall;18(3):34-6.

PMID:
17879766

Supplemental Content

Loading ...
Support Center